Tilføj nøgleord:

Nøgleord på siden:

Klik på ’Tilføj’ for at skrive det nøgleord, som du vil tilføje til siden. Du kan tilføje ét ord eller et samlet udtryk ad gangen.

Klik på ’Se’ for at se, hvilke nøgleord andre brugere har tilknyttet til denne side. Klikker du på et bestemt nøgleord, vil du få en liste over de sider, hvor netop dette nøgleord findes.

Klik på ’Find’ for at komme til en oversigt over alle nøgleord (tagcloud).

Links og litteratur om mistelten

Her kan du læse mere om mistelten:

Hjemmesider:

NCCAM - sider om mistelten på engelsk
National center for Complmentary and Alternative Medicine

Artikler:

Horneber MA, Bueschel G, Huber R, Linde K, Rostock M (2008) Mistletoe therapy in oncology (review). Cochrane database of systematic reviews 2008, issue 2, art. no.: CD003297. DOI:10.1002/14651858.CD003297.pub2

Review - oversigtsartikel om mistelten
Semiglazov VF et al. (2006). Quality of life is improved in breast cancer patients by standardised mistletoe extract PS76A2 during chemotherapy and follow-up: A randomised, placebo-controlled, double-blind, multicentre clinical trial. Anticancer Research 26: 1519-1530 (2006).
Augustin M et al.: Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland. Arzneimittelforschung. 2005;55(1):38-49.
Kleeberg U.R et al.: Final results of the EORTC 18871/DKG 80-1 randomised phase III trial: rIFN-a2b versus rIFN-gamma versus IscadorM versus observation after surgery in melanoma patients with either high-risk primary (thickness>3mm) or regional lymph node metastasis. European Journal of Cancer, 2004; 40:390-402.
Steuer-Vogt et al.: The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial. European Journal of Cancer 37(1):23-31, 2001.
Bussing et al.: Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins. Cancer Letters 99(1): 59-72, 1996.
Kovacs E et al.: Improvement of DNA repair in lymphocytes of breast cancer patients treated with Viscum album extract (Iscador). European Journal of Cancer 27(12): 1672-1676, 1991.
Kuttan G et al.: Effect of a preparation from Viscum album on tumor development in vitro and in mice. Journal of Ethnopharmacology 29(1): 35-41, 1990.
Stettin A et al.: Anti-mistletoe lectin antibodies are produced in patients during therapy with an aqueous mistletoe extract derived from Viscum album L. and neutralize lectin-induced cytotoxicity in vitro. Klinische Wochenschrift 68(18): 896-900, 1990.
Kjaer M.: Mistletoe (Iscador) therapy in stage IV renal adenocarcinoma: a phase II study in patients with measurable lung metastases. Acta Oncologica 28(4): 489-494, 1989.
Schutt C et al.: Selective killing of human monocytes by an immunotoxin containing partially denatured mistletoe lectin I. International Journal of Immunopharmacology 11(8): 977-980, 1989.